Bridging Bench to Bedside: De‑Risking Biotherapeutic Administration via CDMO‑Led Clinical‑Mimic and In‑Use Testing Strategies, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn what clinical in-use studies are and why they matter for biologics safety, efficacy and CMC lifecycle. Attendees will gain insight into... Read more.
Headlamp Health Launches Lumos AI to De-Risk Neuroscience Drug Development
Agentic AI platform brings longitudinal real-world insight to improve trial design and decision-making; Zak Williams and Dr. Charles B. Nemeroff join Board of Advisors... Read more.
Kauhale Healthcare Management to Oversee Kingswood Community
Management transition includes strategic enhancements and $12 million in planned capital improvements WESTERVILLE, Ohio, Jan. 7, 2026 /PRNewswire/ — Kauhale... Read more.
2025’s Top Accounting Solutions Ranked by Info-Tech Research Group for Financial Insight and Operational Efficiency
Using data from authentic end-user reviews, Info-Tech Research Group’s 2025 Accounting Data Quadrant Report highlights the top user-rated accounting solutions... Read more.
Only 17% of Consumers Trust AI Enough to Complete a Purchase, Global Study Finds
A global study of 4,500 consumers shows AI is reshaping product research, but reviews, delivery certainty, and price clarity still determine final purchases NEW... Read more.
Spectral Capital Acquires Intermatica, Expands Global AI- and Quantum-Forward Telecommunications Platform, Advances Revenue Goals
SEATTLE, Jan. 7, 2026 /PRNewswire/ — Spectral Capital Corporation (OTCQB:FCCN) (“Spectral” or the “Company”) today announced the... Read more.
Industrial Scientific Expands Area Monitoring Portfolio with MPS™ LEL Sensor
The new sensor for the Radius® BZ1 improves runtime, reliability, and detection of multiple flammable gases. PITTSBURGH, Jan. 7, 2026 /PRNewswire/ — Industrial... Read more.
Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 7, 2026 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic... Read more.
AtData Launches Gibberish Detection to Strengthen Fraud Intelligence and Block Bot-Generated Identities
New real-time signal identifies and intercepts emails classified as synthetic, random or automated DEDHAM, Mass., Jan. 7, 2026 /PRNewswire/ — AtData, a leading... Read more.
Biobot Analytics Selected by White House Office of National Drug Control Policy to Provide Nationwide Wastewater Intelligence on Substance Use Trends
CAMBRIDGE, Mass., Jan. 7, 2026 /PRNewswire/ — Biobot Analytics, the nation’s leader in wastewater intelligence, today announced it has been awarded a... Read more.